Skip to main content
. 2020 Dec 22;13(1):6. doi: 10.3390/pharmaceutics13010006

Scheme 2.

Scheme 2

Reagents and conditions: (a) EDC, HOBt, NMM, DMF, rt, 15 h; (b) 4 M HCl in 1,4-dioxane, 1,4-dioxane, rt, 3 h; (c) 1a, EDC, HOBt, NMM, DMF, rt, 15 h.